Abiopharma

METALLUS INC. (MTUS) Reports the reporting period Financial Results METALLUS INC. (MTUS) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 1137
• Net Income: $8
• EPS: $3
• Cash and equivalents: $108
  • anticipated increase in throughput is achieved. Further, this news release represents our current policy and intent and is not intended to create legal rights or obligations. Certain standards of measurement and performance contained in this news release are developing and based on assumptions, and no assurance can be given that any plan, objective, initiative, projection, goal, mission, commitment, expectation or prospect set forth in this news release can or will be achieved. Inclusion of information in this news release is not an indication that the subject or information is material to our business or operating results. Additional risks relating to the company's business, the industries in which the company operates, or the company's common shares may be described from time to time in the company's filings with the SEC. All of these risk factors are difficult to predict, are subject to material uncertainties that may affect actual results and may be beyond the company's control. Readers are cautioned that it is not possible to predict or identify all of the risks, uncertainties and other factors that 5 may affect future results and that the above list should not be considered to be a complete list. Except as required by the federal securities laws, the company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. 6 CONSOLIDATED STATEMENTS OF OPERATIONS Three Months EndedJune 30, Six Months EndedJune 30, (in millions, except per share data) (Unaudited) 2026